BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8878899)

  • 1. Heparan sulphate in breast cancer cells.
    Rahmoune H; Turnbull JE; Gallagher JT; Rudland PS; Fernig DG
    Biochem Soc Trans; 1996 Aug; 24(3):355S. PubMed ID: 8878899
    [No Abstract]   [Full Text] [Related]  

  • 2. Changes in glycosaminoglycan structure and composition of the main heparan sulphate proteoglycan from human colon carcinoma cells (perlecan) during cell differentiation.
    Molist A; Romarís M; Lindahl U; Villena J; Touab M; Bassols A
    Eur J Biochem; 1998 Jun; 254(2):371-7. PubMed ID: 9660193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased deposition of glycosaminoglycans and altered structure of heparan sulfate in idiopathic pulmonary fibrosis.
    Westergren-Thorsson G; Hedström U; Nybom A; Tykesson E; Åhrman E; Hornfelt M; Maccarana M; van Kuppevelt TH; Dellgren G; Wildt M; Zhou XH; Eriksson L; Bjermer L; Hallgren O
    Int J Biochem Cell Biol; 2017 Feb; 83():27-38. PubMed ID: 27974233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradation of heparan sulfate with heparin lyases.
    LeBrun LA; Linhardt RJ
    Methods Mol Biol; 2001; 171():353-61. PubMed ID: 11450249
    [No Abstract]   [Full Text] [Related]  

  • 5. Matrix heparan sulphate, but not endothelial cell surface heparan sulphate, is degraded by highly metastatic mouse lymphoma cells.
    Hennes R; Frantzen F; Keller R; Schirrmacher V; Schwartz-Albiez R
    Br J Cancer; 1988 Aug; 58(2):186-8. PubMed ID: 2971387
    [No Abstract]   [Full Text] [Related]  

  • 6. Distinct heparan sulfate glycosaminoglycans are responsible for mediating fibroblast growth factor-2 biological activity through different fibroblast growth factor receptors.
    Berry D; Kwan CP; Shriver Z; Venkataraman G; Sasisekharan R
    FASEB J; 2001 Jun; 15(8):1422-4. PubMed ID: 11387244
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation and Characterization of a Chinese Hamster Ovary Heparan Sulfate Cell Mutant Defective in Both Met Receptor Binding and Hepatocyte Growth Factor NK1/Met Signaling.
    Cao T; Pan J; Li X; He Y; Jiang Y; Chang Y; Zhang Q; Lan Y; Wang H; Jiao W; Tian Z; Zhang L
    Cell Physiol Biochem; 2018; 48(4):1480-1491. PubMed ID: 30107380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A computational approach for deciphering the organization of glycosaminoglycans.
    Spencer JL; Bernanke JA; Buczek-Thomas JA; Nugent MA
    PLoS One; 2010 Feb; 5(2):e9389. PubMed ID: 20186334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparan sulphate proteoglycans.
    Gallagher JT; Turnbull JE; Lyon M
    Biochem Soc Trans; 1990 Apr; 18(2):207-9. PubMed ID: 2143154
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparan sulphate: functional role as a modulator of fibroblast growth factor activity.
    Turnbull JE; Gallagher JT
    Biochem Soc Trans; 1993 May; 21(2):477-82. PubMed ID: 8359514
    [No Abstract]   [Full Text] [Related]  

  • 11. Disaccharide composition of heparan sulfates: brain, nervous tissue storage organelles, kidney, and lung.
    Tekotte H; Engel M; Margolis RU; Margolis RK
    J Neurochem; 1994 Mar; 62(3):1126-30. PubMed ID: 8113800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparan sulphate glycosaminoglycans derived from endothelial cells and smooth muscle cells differentially modulate fibroblast growth factor-2 biological activity through fibroblast growth factor receptor-1.
    Berry D; Shriver Z; Natke B; Kwan CP; Venkataraman G; Sasisekharan R
    Biochem J; 2003 Jul; 373(Pt 1):241-9. PubMed ID: 12659634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions that influence the binding of synthetic heparan sulfate based disaccharides to fibroblast growth factor-2.
    Li YC; Ho IH; Ku CC; Zhong YQ; Hu YP; Chen ZG; Chen CY; Lin WC; Zulueta MM; Hung SC; Lin MG; Wang CC; Hsiao CD
    ACS Chem Biol; 2014 Aug; 9(8):1712-7. PubMed ID: 24959968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two hierarchies of FGF-2 signaling in heparin: mitogenic stimulation and high-affinity binding/receptor transphosphorylation.
    Krufka A; Guimond S; Rapraeger AC
    Biochemistry; 1996 Aug; 35(34):11131-41. PubMed ID: 8780517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural differences between heparan sulphates of proteoglycan involved in the formation of basement membranes in vivo by Lewis-lung-carcinoma-derived cloned cells with different metastatic potentials.
    Nakanishi H; Oguri K; Yoshida K; Itano N; Takenaga K; Kazama T; Yoshida A; Okayama M
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):215-24. PubMed ID: 1445266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in the distribution of O-sulphate groups of cell-surface and secreted heparan sulphate produced by human neuroblastoma cells in culture.
    Hampson IN; Kumar S; Gallagher JT
    Biochim Biophys Acta; 1983 Sep; 763(2):183-90. PubMed ID: 6225467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary manganese affects the concentration, composition and sulfation pattern of heparan sulfate glycosaminoglycans in Sprague-Dawley rat aorta.
    Kalea AZ; Lamari FN; Theocharis AD; Schuschke DA; Karamanos NK; Klimis-Zacas DJ
    Biometals; 2006 Oct; 19(5):535-46. PubMed ID: 16937260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of flavobacterial glycuronidases acting on disaccharides derived from glycosaminoglycans.
    Hovingh P; Linker A
    Biochem J; 1977 Aug; 165(2):287-93. PubMed ID: 921751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulphates as membrane receptors for the fibroblast growth factors.
    Gallagher JT
    Eur J Clin Chem Clin Biochem; 1994 Apr; 32(4):239-47. PubMed ID: 8038264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foam cell conversion of macrophages alters the biosynthesis of heparan sulfate.
    Ghiselli G; Lindahl U; Salmivirta M
    Biochem Biophys Res Commun; 1998 Jun; 247(3):790-5. PubMed ID: 9647772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.